Cargando…

DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that can develop into an aggressive form called nonalcoholic steatohepatitis (NASH), which ultimately progresses to cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver failure. Currently, the deterioratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Halaka, Diana, Shpaizer, Adi, Zeigerman, Haim, Kanner, Joseph, Tirosh, Oren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952671/
https://www.ncbi.nlm.nih.gov/pubmed/36830070
http://dx.doi.org/10.3390/antiox12020512
_version_ 1784893689742491648
author Abu-Halaka, Diana
Shpaizer, Adi
Zeigerman, Haim
Kanner, Joseph
Tirosh, Oren
author_facet Abu-Halaka, Diana
Shpaizer, Adi
Zeigerman, Haim
Kanner, Joseph
Tirosh, Oren
author_sort Abu-Halaka, Diana
collection PubMed
description Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that can develop into an aggressive form called nonalcoholic steatohepatitis (NASH), which ultimately progresses to cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver failure. Currently, the deterioration of NAFLD is attributed to specific lipid toxicity which could be due to lipotoxicity and/or ferroptosis. In the current study, we evaluated the involvement of the nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf-2), which is a main activator of phase II metabolism in the two types of lipid-induced toxicity in hepatocytes, lipotoxicity by saturated fatty acids, and in ferroptosis, and the effect of NO donor treatment. AML12 cells were exposed to 600 μM palmitic acid to induce lipotoxicity or treated with 20 μM erastin or 5 μM RSL3 for ferroptosis. In SFA-lipotoxicity, pretreatment with the Nrf2 activator dimethyl fumarate (DMF) managed to ameliorate the cells and the oxidative stress level while aggravating ferroptosis due to emptying the thiol pool. On the other hand, the nitric oxide (NO)-donor, S-nitroso-N-acetylcysteine (NAC-SNO) proved to be effective in the prevention of hepatocytes ferroptosis.
format Online
Article
Text
id pubmed-9952671
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99526712023-02-25 DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine Abu-Halaka, Diana Shpaizer, Adi Zeigerman, Haim Kanner, Joseph Tirosh, Oren Antioxidants (Basel) Article Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that can develop into an aggressive form called nonalcoholic steatohepatitis (NASH), which ultimately progresses to cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver failure. Currently, the deterioration of NAFLD is attributed to specific lipid toxicity which could be due to lipotoxicity and/or ferroptosis. In the current study, we evaluated the involvement of the nuclear factor erythroid 2 (NFE2)-related factor 2 (Nrf-2), which is a main activator of phase II metabolism in the two types of lipid-induced toxicity in hepatocytes, lipotoxicity by saturated fatty acids, and in ferroptosis, and the effect of NO donor treatment. AML12 cells were exposed to 600 μM palmitic acid to induce lipotoxicity or treated with 20 μM erastin or 5 μM RSL3 for ferroptosis. In SFA-lipotoxicity, pretreatment with the Nrf2 activator dimethyl fumarate (DMF) managed to ameliorate the cells and the oxidative stress level while aggravating ferroptosis due to emptying the thiol pool. On the other hand, the nitric oxide (NO)-donor, S-nitroso-N-acetylcysteine (NAC-SNO) proved to be effective in the prevention of hepatocytes ferroptosis. MDPI 2023-02-17 /pmc/articles/PMC9952671/ /pubmed/36830070 http://dx.doi.org/10.3390/antiox12020512 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Abu-Halaka, Diana
Shpaizer, Adi
Zeigerman, Haim
Kanner, Joseph
Tirosh, Oren
DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title_full DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title_fullStr DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title_full_unstemmed DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title_short DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
title_sort dmf-activated nrf2 ameliorates palmitic acid toxicity while potentiates ferroptosis mediated cell death: protective role of the no-donor s-nitroso-n-acetylcysteine
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952671/
https://www.ncbi.nlm.nih.gov/pubmed/36830070
http://dx.doi.org/10.3390/antiox12020512
work_keys_str_mv AT abuhalakadiana dmfactivatednrf2amelioratespalmiticacidtoxicitywhilepotentiatesferroptosismediatedcelldeathprotectiveroleofthenodonorsnitrosonacetylcysteine
AT shpaizeradi dmfactivatednrf2amelioratespalmiticacidtoxicitywhilepotentiatesferroptosismediatedcelldeathprotectiveroleofthenodonorsnitrosonacetylcysteine
AT zeigermanhaim dmfactivatednrf2amelioratespalmiticacidtoxicitywhilepotentiatesferroptosismediatedcelldeathprotectiveroleofthenodonorsnitrosonacetylcysteine
AT kannerjoseph dmfactivatednrf2amelioratespalmiticacidtoxicitywhilepotentiatesferroptosismediatedcelldeathprotectiveroleofthenodonorsnitrosonacetylcysteine
AT tiroshoren dmfactivatednrf2amelioratespalmiticacidtoxicitywhilepotentiatesferroptosismediatedcelldeathprotectiveroleofthenodonorsnitrosonacetylcysteine